The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeGrowth
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IHI | 49.91 | 0.26 | +0.52% |
| iShares US Medical Devices ETF | |||
| DGLO | 23.75 | N/A | N/A |
| First Trust RBA Deglobalization ETF | |||
| LRGG | 27.85 | -0.03 | -0.11% |
| Nomura Focused Large Growth ETF | |||
| BIB | 83.11 | -0.60 | -0.72% |
| ProShares Ultra Nasdaq Biotechnology | |||
| FDG | 134.70 | -0.99 | -0.73% |
| American Century Foc Dynmc Gr ETF | |||
A.I.dvisor indicates that over the last year, MSPRX has been closely correlated with RGACX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MSPRX jumps, then RGACX could also see price increases.
| Ticker / NAME | Correlation To MSPRX | 1D Price Change % | ||
|---|---|---|---|---|
| MSPRX | 100% | N/A | ||
| RGACX - MSPRX | 87% Closely correlated | -0.90% | ||
| RGAGX - MSPRX | 87% Closely correlated | -0.91% | ||
| RGAEX - MSPRX | 87% Closely correlated | -0.90% | ||
| RGEBX - MSPRX | 82% Closely correlated | -0.91% | ||
| GAFFX - MSPRX | 82% Closely correlated | -0.90% | ||
More | ||||